BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12872266)

  • 1. Neurofibromatosis type 1 (NF1): Identification of eight unreported mutations in NF1 gene in Italian patients [corrected].
    Origone P; Bellini C; Sambarino D; Banelli B; Morcaldi G; La Rosa C; Stanzial F; Castellan C; Coviello DA; Garrè C; Bonioli E
    Hum Mutat; 2003 Aug; 22(2):179-80. PubMed ID: 12872266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten novel mutations in the human neurofibromatosis type 1 (NF1) gene in Italian patients.
    Origone P; De Luca A; Bellini C; Buccino A; Mingarelli R; Costabel S; La Rosa C; Garrè C; Coviello DA; Ajmar F; Dallapiccola B; Bonioli E
    Hum Mutat; 2002 Jul; 20(1):74-5. PubMed ID: 12112660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
    Messiaen LM; Callens T; Mortier G; Beysen D; Vandenbroucke I; Van Roy N; Speleman F; Paepe AD
    Hum Mutat; 2000; 15(6):541-55. PubMed ID: 10862084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1.
    De Luca A; Schirinzi A; Buccino A; Bottillo I; Sinibaldi L; Torrente I; Ciavarella A; Dottorini T; Porciello R; Giustini S; Calvieri S; Dallapiccola B
    Hum Mutat; 2004 Jun; 23(6):629. PubMed ID: 15146469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs).
    Upadhyaya M; Spurlock G; Majounie E; Griffiths S; Forrester N; Baser M; Huson SM; Gareth Evans D; Ferner R
    Hum Mutat; 2006 Jul; 27(7):716. PubMed ID: 16786508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF1 mutation analysis using a combined heteroduplex/SSCP approach.
    Abernathy CR; Rasmussen SA; Stalker HJ; Zori R; Driscoll DJ; Williams CA; Kousseff BG; Wallace MR
    Hum Mutat; 1997; 9(6):548-54. PubMed ID: 9195229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
    Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
    Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two independent mutations in a family with neurofibromatosis type 1 (NF1).
    Klose A; Peters H; Hoffmeyer S; Buske A; Lüder A; Hess D; Lehmann R; Nürnberg P; Tinschert S
    Am J Med Genet; 1999 Mar; 83(1):6-12. PubMed ID: 10076878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.
    Kinoshita K; Hirota S; Isozaki K; Ohashi A; Nishida T; Kitamura Y; Shinomura Y; Matsuzawa Y
    J Pathol; 2004 Jan; 202(1):80-5. PubMed ID: 14694524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation screening of neurofibromatosis type 1 (NF1) exons 28 and 29 with single strand conformation polymorphism (SSCP): five novel mutations, one recurrent transition and two polymorphisms in a panel of 118 unrelated NF1 patients. Mutations in brief no. 229. Online.
    Peters H; Lüder A; Harder A; Schuelke M; Tinschert S
    Hum Mutat; 1999; 13(3):258. PubMed ID: 10090487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of neurofibromatosis type 1 mutations.
    Weiming X; Yu Q; Lizhi L; Ponder M; Wallace M; Gangfeng X; Ponder B
    Hum Mutat; 1992; 1(6):474-7. PubMed ID: 1301957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
    Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
    J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and recurrent mutations in the neurofibromatosis type 1 (NF1) gene.
    Hudson J; Wu CL; Tassabehji M; Summers EM; Simon S; Super M; Donnai D; Thakker N
    Hum Mutat; 1997; 9(4):366-7. PubMed ID: 9101300
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene.
    Upadhyaya M; Osborn M; Maynard J; Harper P
    Am J Med Genet; 1996 Jul; 67(4):421-3. PubMed ID: 8837715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutional NF1 mutations in neurofibromatosis 1 patients with malignant peripheral nerve sheath tumors.
    Kluwe L; Friedrich RE; Peiper M; Friedman J; Mautner VF
    Hum Mutat; 2003 Nov; 22(5):420. PubMed ID: 14517963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mutations in NF1 patients with malignancies.
    Wu R; López-Correa C; Rutkowski JL; Baumbach LL; Glover TW; Legius E
    Genes Chromosomes Cancer; 1999 Dec; 26(4):376-80. PubMed ID: 10534774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of CpG C-to-T mutations in neurofibromatosis type 1. Mutations in brief no. 129. Online.
    Krkljus S; Abernathy CR; Johnson JS; Williams CA; Driscoll DJ; Zori R; Stalker HJ; Rasmussen SA; Collins FS; Kousseff BG; Baumbach L; Wallace MR
    Hum Mutat; 1998; 11(5):411. PubMed ID: 10336779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF1 gene analysis based on DHPLC.
    De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
    Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three different premature stop codons lead to skipping of exon 7 in neurofibromatosis type I patients.
    Wimmer K; Eckart M; Stadler PF; Rehder H; Fonatsch C
    Hum Mutat; 2000 Jul; 16(1):90-1. PubMed ID: 10874316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of novel NF1 mutations and rapid mutation prescreening with Pyrosequencing.
    Brinckmann A; Mischung C; Bässmann I; Kühnisch J; Schuelke M; Tinschert S; Nürnberg P
    Electrophoresis; 2007 Dec; 28(23):4295-301. PubMed ID: 18041031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.